Many Veterans Who Died from Opioid Overdoses Had Also Received Benzos
the Clinical Pain Advisor take:
Half of veterans who died from drug overdoses had been prescribed both opioids, for pain, as well as benzodiazepines for conditions like anxiety, and insomnia, according to a recent analysis of post mortem VA records conducted and presented by by Rhode Island Hospital, Boston Medical Center, and the Veteran Affairs Ann Arbor Healthcare Systems
Veterans that were prescribed both opioids and benzodiazepines in a higher dosage were at a greater risk of death than those who were given a lower dosage.
Patient records of veterans who died from drug overdoses while receiving medical services as an outpatient at the Veterans Health Administration between October 2004 and September 2009 were examined for the relationship between the opioids and benzodiazepines when prescribed concurrently.
"From a public health perspective, this is deeply troubling, because drug overdoses are a leading cause of death in the U.S. and prescribing benzodiazepines to patients taking opioids for pain is quite common. In 2010, 75% of pharmaceutical-related drug-overdose deaths involved opioids," said Tae Woo Park, MD, attending physician at Rhode Island Hospital "As we learn more about pharmaceuticals and how they interact with each other, we can try to reduce the risk of harm to patients.”
Hydrocodone painkillers face increased federal restriction
Veterans prescribed higher doses of benzodiazepines while concurrently receiving opioids were at greater risk of overdose death than those on lower doses of benzodiazepines.
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Half of Patients Referred for Behavioral Treatment of Migraine Never Initiate Treatment
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness